Rheumatoid Arthritis Clinical Trials in Phoenix

Showing 1461-1480 of 1,527 trials

Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Cornea

NCT01057147

The purpose of this study is to evaluate the safety and efficacy of 2% rebamipide compared to placebo in clearing of fluorescein staining of the central cornea in subjects with dry eye disease.

Keratoconjunctivitis SiccaDry Eye

Kubota Vision Inc.116 participantsStarted Feb 2010

Mesa, Arizona, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +16 more locations

COMPLETEDPhase 2< 1 mile

Safety and Efficacy of PP4001 for the Treatment of Symptoms Associated With Uncomplicated Urinary Tract Infection

NCT01406587

PP4001 is a medication not yet approved by the US FDA. This is a phase 2, multi-center, randomized, double-blind study of 3 doses of PP4001 versus placebo in the treatment of symptoms associated with uncomplicated urinary tract infection. After the screening, patients are randomized to receive one of three doses of PP4001 or placebo. Patients are screened and randomized on the same day, and take 4 doses of study drug, one dose every 12 hours. Data about uncomplicated urinary tract infection symptoms are collected from the subjects on electronic handheld devices throughout the 48-hour study period. The primary endpoint is burning during urination.

Urinary Tract Infection

Pinnacle Pharmaceuticals, Inc.261 participantsStarted Jul 2011

Montgomery, Alabama, United States • Mesa, Arizona, United States • Mesa, Arizona, United States +22 more locations

Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Cornea

Safety and Efficacy of PP4001 for the Treatment of Symptoms Associated With Uncomplicated Urinary Tract Infection

Rheumatoid Arthritis Trials in Other Cities

Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation

Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy

Occipital Nerve Stimulation for the Treatment of Chronic Migraine Headache.

Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors

Study to Evaluate the Safety and Analgesic Activity of ATx08-001 in Subjects With Postherpetic Neuralgia

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

Study of Levalbuterol and Racemic Albuterol in Pediatric Subjects With Reactive Airways Disease (RAD)

Hypertonic Resuscitation Following Severe Traumatic Brain Injury (TBI)

A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS

International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430

A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS

A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After Bunionectomy

A Study of the Safety and Pharmacokinetics of PRO283698 in Patients With Rheumatoid Arthritis

A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain Injury.

DPBRN Persistent Pain and Root Canal Therapy

DPBRN Peri-operative Pain and Root Canal Therapy

Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity

The Simple ECG Monitoring Trial (Comparison of a Novel Recording System With a Standard Holter Monitor)

Other Conditions in Phoenix